Acknowledgement
ASCI-PT 2020 was supported by Dongkook Life Science and Circle financially. We thank them for their support.
References
- Allman KC, Shaw LJ, Hachamovitch R, Udelson JE. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002;39:1151-1158 https://doi.org/10.1016/S0735-1097(02)01726-6
- Catalano O, Moro G, Perotti M, Frascaroli M, Ceresa M, Antonaci S, et al. Late gadolinium enhancement by cardiovascular magnetic resonance is complementary to left ventricle ejection fraction in predicting prognosis of patients with stable coronary artery disease. J Cardiovasc Magn Reson 2012;14:29
- Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-2743 https://doi.org/10.1161/CIRCULATIONAHA.105.570648
- Zemrak F, Petersen SE. Late gadolinium enhancement CMR predicts adverse cardiovascular outcomes and mortality in patients with coronary artery disease: systematic review and meta-analysis. Prog Cardiovasc Dis 2011;54:215-229 https://doi.org/10.1016/j.pcad.2011.07.003
- Jimenez Juan L, Crean AM, Wintersperger BJ. Late gadolinium enhancement imaging in assessment of myocardial viability: techniques and clinical applications. Radiol Clin North Am 2015;53:397-411 https://doi.org/10.1016/j.rcl.2014.11.004
- Buckert D, Cieslik M, Tibi R, Radermacher M, Rottbauer W, Bernhardt P. Cardiac magnetic resonance imaging derived quantification of myocardial ischemia and scar improves risk stratification and patient management in stable coronary artery disease. Cardiol J 2017;24:293-304 https://doi.org/10.5603/CJ.a2017.0036
- Wolk MJ, Bailey SR, Doherty JU, Douglas PS, Hendel RC, Kramer CM, et al. ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons. J Am Coll Cardiol 2014;63:380-406 https://doi.org/10.1016/j.jacc.2013.11.009
- Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, Pilz G, et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry--multi national results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013;15:9
- Schulz-Menger J, Bluemke DA, Bremerich J, Flamm SD, Fogel MA, Friedrich MG, et al. Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) board of trustees task force on standardized post processing. J Cardiovasc Magn Reson 2013;15:35
- Im DJ, Hong SJ, Park EA, Kim EY, Jo Y, Kim J, et al. Guidelines for cardiovascular magnetic resonance imaging from the Korean Society of Cardiovascular Imaging-part 3: perfusion, delayed enhancement, and T1- and T2 mapping. Korean J Radiol 2019;20:1562-1582 https://doi.org/10.3348/kjr.2019.0411
- Lee JW, Hur JH, Yang DH, Lee BY, Im DJ, Hong SJ, et al. Guidelines for cardiovascular magnetic resonance imaging from the Korean Society of Cardiovascular Imaging-part 2: interpretation of cine, flow, and angiography data. Korean J Radiol 2019;20:1477-1490 https://doi.org/10.3348/kjr.2019.0407
- Jo Y, Kim J, Park CH, Lee JW, Hur JH, Yang DH, et al. Guideline for cardiovascular magnetic resonance imaging from the Korean Society of Cardiovascular Imaging-part 1: standardized protocol. Korean J Radiol 2019;20:1313-1333 https://doi.org/10.3348/kjr.2019.0398
- Park CH, Kim C, Lee BY, Park CH, Kang EJ, Koo HJ, et al. Semi-quantitative scoring of late gadolinium enhancement of the left ventricle in patients with ischemic cardiomyopathy: consensus statement from the Asian Society of Cardiovascular Imaging-Practical Tutorial (ASCI-PT). Cardiovasc Imaging Asia 2021;5:26-36 https://doi.org/10.22468/cvia.2021.00024
- Kottner J, Audige L, Brorson S, Donner A, Gajewski BJ, Hrobjartsson A, et al. Guidelines for reporting reliability and agreement studies (GRRAS) were proposed. Int J Nurs Stud 2011;48:661-671 https://doi.org/10.1016/j.ijnurstu.2011.01.016
- de Vet HC, Terwee CB, Knol DL, Bouter LM. When to use agreement versus reliability measures. J Clin Epidemiol 2006;59:1033-1039 https://doi.org/10.1016/j.jclinepi.2005.10.015
- Fleiss JL. Measuring nominal scale agreement among many raters. Psychol Bull 1971;76:378-382 https://doi.org/10.1037/h0031619
- Benchoufi M, Matzner-Lober E, Molinari N, Jannot AS, Soyer P. Interobserver agreement issues in radiology. Diagn Interv Imaging 2020;101:639-641 https://doi.org/10.1016/j.diii.2020.09.001
- Foppen W, van der Schaaf IC, Beek FJ, Verkooijen HM, Fischer K. Scoring haemophilic arthropathy on X-rays: improving inter- and intra-observer reliability and agreement using a consensus atlas. Eur Radiol 2016;26:1963-1970 https://doi.org/10.1007/s00330-015-4013-8
- Jones M, Dobson A, O'Brian S. A graphical method for assessing agreement with the mean between multiple observers using continuous measures. Int J Epidemiol 2011;40:1308-1313 https://doi.org/10.1093/ije/dyr109
- Wu YW, Tadamura E, Yamamuro M, Kanao S, Marui A, Tanabara K, et al. Comparison of contrast-enhanced MRI with 18F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease. J Nucl Med 2007;48:1096-1103 https://doi.org/10.2967/jnumed.106.038596
- Kwon DH, Halley CM, Carrigan TP, Zysek V, Popovic ZB, Setser R, et al. Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study. JACC Cardiovasc Imaging 2009;2:34-44 https://doi.org/10.1016/j.jcmg.2008.09.010
- Bondarenko O, Beek AM, Twisk JW, Visser CA, van Rossum AC. Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. Eur Heart J 2008;29:2000-2005 https://doi.org/10.1093/eurheartj/ehn266
- Panza JA, Ellis AM, Al-Khalidi HR, Holly TA, Berman DS, Oh JK, et al. Myocardial viability and long-term outcomes in ischemic cardiomyopathy. N Engl J Med 2019;381:739-748 https://doi.org/10.1056/NEJMoa1807365
- Setser RM, Bexell DG, O'Donnell TP, Stillman AE, Lieber ML, Schoenhagen P, et al. Quantitative assessment of myocardial scar in delayed enhancement magnetic resonance imaging. J Magn Reson Imaging 2003;18:434-441 https://doi.org/10.1002/jmri.10391
- Glaveckaite S, Valeviciene N, Palionis D, Skorniakov V, Celutkiene J, Tamosiunas A, et al. Value of scar imaging and inotropic reserve combination for the prediction of segmental and global left ventricular functional recovery after revascularisation. J Cardiovasc Magn Reson 2011;13:35